Login / Signup

Polygenic effect on tau pathology progression in Alzheimer's disease.

Anna RubinskiSimon FrerichRainer MalikNicolai FranzmeierAlfredo RamirezMartin DichgansMichael Ewersnull null
Published in: Annals of neurology (2022)
Our results demonstrate that the PGS predicts faster tau progression and thus cognitive decline, showing utility to enhance statistical power in clinical trials. This article is protected by copyright. All rights reserved.
Keyphrases
  • cognitive decline
  • mild cognitive impairment
  • clinical trial
  • cerebrospinal fluid
  • study protocol